Metropolis Healthcare Limited (BOM:542650)
India · Delayed Price · Currency is INR | Market Cap | 100.02B |
| Revenue (ttm) | 14.04B |
| Net Income (ttm) | 1.52B |
| Shares Out | n/a |
| EPS (ttm) | 29.45 |
| PE Ratio | 65.77 |
| Forward PE | 46.27 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,054 |
| Average Volume | 3,980 |
| Open | 1,949.00 |
| Previous Close | 1,944.70 |
| Day's Range | 1,935.25 - 1,987.50 |
| 52-Week Range | 1,383.70 - 2,261.85 |
| Beta | n/a |
| RSI | 37.87 |
| Earnings Date | Nov 7, 2025 |
About Metropolis Healthcare
Metropolis Healthcare Limited, together with its subsidiaries, provides pathology and related healthcare services in India, Africa, South Asia, the Middle East, and internationally. The company offers routine and semi-specialised pathology tests; advanced diagnostics, including genetic, molecular, and cytogenetic testing; preventive healthcare packages and corporate wellness screening; and clinical trial research, hospital lab management, and home collection services, as well as profiles, blood tests, and soft radiology services. It also provid... [Read more]
Financial Performance
In 2024, Metropolis Healthcare's revenue was 13.31 billion, an increase of 10.23% compared to the previous year's 12.08 billion. Earnings were 1.45 billion, an increase of 13.42%.
Financial StatementsNews
Metropolis Healthcare incorporates new subsidiary Metropolis Quality Solutions
Metropolis Healthcare Limited on Tuesday announced the incorporation of a new wholly owned subsidiary, Metropolis Quality Solutions Private Limited, effective September 15, 2025. The newly incorporate...
Metropolis Healthcare shares jump nearly 3% following Q1 results; Company projects over 12% revenue growth in FY26
Shares of Metropolis Healthcare Ltd surged 2.86% to ₹2,065.90 on Monday, adding ₹57.50 in early trade. The stock, listed on NSE, has a market capitalisation of ₹10,513.48 crore and has traded between ...
Metropolis Healthcare eyes double-digit growth as B2C gains traction
Nuvama Institutional Equities has reiterated a ‘Buy’ rating on Metropolis Healthcare, maintaining its target price at ₹2,240 per share. The brokerage cited improving business mix, strong B2C performan...
Metropolis Healthcare shares rise over 2% today as specialty and TruHealth segments post strong Q1 growth
On Monday, 7th July, shares of Metropolis Healthcare Ltd gained 2.35% to ₹1,815 on the NSE, rising ₹41.70 from the previous close of ₹1,773.30. The stock moved higher after the company shared its busi...
Metropolis Healthcare to acquire Dr. Ahujas’ Pathology & Imaging Centre for Rs 35 crore
Metropolis Healthcare Limited, India’s second-largest pathology laboratory chain, has announced a strategic acquisition to bolster its foothold in North India. The company’s wholly owned subsidiary, M...
Metropolis Healthcare posts 10% YoY revenue growth in Q4 FY25, wellness segment drives performance
Metropolis Healthcare Limited reported a 10% year-on-year revenue growth for the fourth quarter of FY25, despite facing challenges in the acute testing and specialty segments. The company, which opera...
Stocks hitting 52-week low today, April 1: Titan Company, Tata Elxsi, UCO Bank, Birlasoft, Metropolis Healthcare and more
The Indian stock market experienced a significant downturn on April 1, as both major indices, Sensex and Nifty, closed in the red for the second consecutive session. The Sensex plunged by 1,390.41 poi...
Metropolis Healthcare to acquire scientific pathology’s business in Agra for up to Rs 83 Crore
Metropolis Healthcare Limited has announced the acquisition of the business operations of Dr. Ashok Kumar Sharma’s Scientific Pathology, a diagnostic service provider in Agra and neighboring towns. Th...
Metropolis Health shares jump 3% as revenue rises 11% YoY in Q3
Metropolis Health shares jumped more than 3% in morning trade after the company announced its solid Q3 results. As of 10:09 AM, the shares were trading 2.85% higher at Rs 1,787.45. The company posted ...
Metropolis Healthcare Q3 FY25 results: Revenue Up 9.2% YoY to Rs 29,991.31 lakhs, net profit soars 2.6% YoY
In December 2024, the company announced the acquisition of Core Diagnostics Private Limited, a leading diagnostic service provider in India, for ₹24,683 lakhs. This acquisition is expected to enhance ...
Metropolis Healthcare Ltd (BOM:542650) Q3 2025 Earnings Report Preview: What To Look For
Metropolis Healthcare Ltd (BOM:542650) Q3 2025 Earnings Report Preview: What To Look For